Daniel P. O'Connell, Director at LogicBio Therapeutics, Inc. (LOGC), bought 2,979,023 shares at $10.00 ($7.0M) on 2018-10-23, disclosed to the SEC on 2018-10-25.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 2,279,023 | $0 | 0.0% |
| 2 | $10.00 | 700,000 | $7.0M | 100.0% |
| Total | $2.35 avg | 2,979,023 | $7.0M | 100% |